The race to commercialize the world’s most powerful psychedelic

An obscure and extremely powerful psychedelic called 5-MeO-DMT is drawing intense interest from the pharmaceutical industry, where biotech companies are racing to turn it into a commercially available treatment for severe mental health disorders, like depression, anxiety and PTSD.

Watch the Journal’s inside look at how the psychedelic is being used at unregulated clinics, and why companies are betting that it could soon turn into a billion-dollar blockbuster drug.

Write to Roberto Ferdman at [email protected] and Alexander Hotz at [email protected]